IN THE NEWS

Albuterol

16January2026

How Ritedose Supports a Stable and Reliable Medication Supply

Learn how Ritedose safeguards patients’ access to critical medications with responsive, high-quality pharmaceutical manufacturing.

Automated pharmaceutical warehouse with a yellow robotic arm stacking cardboard boxes, illustrating Ritedose’s focus on transparency, efficiency, and solutions for drug shortages.

23December2025

Ritedose 2025 Year-In-Review

Ritedose’s 2025 Year-In-Review highlights a year of growth, innovation, and purpose-driven impact, advancing patient access through expanded generics, operational excellence, and community investment.

Automated pharmaceutical warehouse with a yellow robotic arm stacking cardboard boxes, illustrating Ritedose’s focus on transparency, efficiency, and solutions for drug shortages.

19May2025

Ritedose Pharmaceuticals Receives FDA Approval for Albuterol Sulfate Inhalation Solution, 0.5% (2.5 mg/0.5 mL)*—Addressing Nationwide Shortage of the Essential Drug

COLUMBIA, SC May 20, 2025 —Ritedose Pharmaceuticals, a division of The Ritedose Corporation (Ritedose), the largest sterile contract development manufacturing organization (CDMO) in the US specializing in aseptic unit-dose medication production using Blow-Fill-Seal (BFS) technology, received US Food and Drug…

FDA approval for albuterol sulfate Solution

FEATURED NEWS

11th February 2026

South Carolina Life Sciences Momentum: Ritedose Helps Fuel a Fast-Growing Innovation Hub

South Carolina Life Sciences innovation led by Ritedose manufacturing expansion

30th January 2026

Introducing Ritedose— the Largest CDMO Specializing in Blow-Fill-Seal Technology in the US

Ritedose Blow-Fill-Seal Technology | Aerial view of Ritedose pharmaceutical manufacturing facilities in Columbia, South Carolina, showcasing the largest U.S. Blow-Fill-Seal CDMO.

16th January 2026

How Ritedose Supports a Stable and Reliable Medication Supply

Automated pharmaceutical warehouse with a yellow robotic arm stacking cardboard boxes, illustrating Ritedose’s focus on transparency, efficiency, and solutions for drug shortages.

24th September 2025

Leading CDMO Enhances cGMP Lab Infrastructure to Strengthen Position

male scientist mixing chemicals in lab with text overlay "$17M expansion"

16th September 2025

How Blow-Fill-Seal Technology Ensures Sterile Medication Delivery

18th June 2025

Ritedose Unveils State-of-the-Art Distribution and Logistics Facility at Ritedose Performance Park

Stakeholders open the Ritedose distribution and logistics facility at Performance Park. L–R: Brian Taylor, VP Business Development, Miller Valentine Construction Jeff Ruble, Director, Richland County Economic Development Ashely Teasdel, Deputy Secretary, SC Dept. of Commerce Jody Chastain, CEO, Ritedose Jesica Mackey, Richland County Council District 9 Daniel Rickenmann, Mayor, City of Columbia Ronald Rhames, Fmr. President, Midlands Technical College Greg Little, President, Midlands Technical College

15th April 2025

Ritedose Adds Seventh Syntegon Packaging Line to Expand Single Vial Packaging Capabilities, Support Production of new COPD Drug Ohtuvayre

16th September 2024

Ritedose is Proud to Partner with Verona Pharma to Deliver First-In-Class COPD Drug, Ohtuvayre (ensifentrine)*

11th July 2024

Ritedose, the Leading Pharmaceutical Manufacturer (CDMO) Specializing in Sterile Blow-Fill-Seal, Expands its BFS Capacity to Meet the Growing Demand f…

18th January 2022

The Ritedose Corporation Announces Revolutionary Liquid Med Dispenser SuredoseRx™ to launch in first quarter

RECEIVE THE LATEST NEWS

Get a healthy dose of all things Ritedose. Subscribe now for breaking news alerts, updates, previews, and more.

TAGS CLOUD